Hematein

Cat. No.: OB0225WX-1656

Purity: ≥95%

Identity: Confirmed by NMR.

Size:

INQUIRY Datasheet MSDS

Add to basket

Product Overview

Description: Hematein is an allosteric Casein kinase II inhibitor (IC50: 0.74 μM) and an oxidation product of hematoxylin that suppresses the Wnt/TCF pathway and Akt/PKB Ser129 phosphorylation.

Synonym: Hydroxybrasilein; 475-25-2; Haematein; Hematine; 3,4,6a,10-tetrahydroxy-6,7-dihydroindeno[2,1-c]chromen-9-one; Benz[b]indeno[1,2-d]pyran-9(6H)-one, 6a,7-dihydro-3,4,6a,10-tetrahydroxy-; 6a,7-Dihydro-3,4,6a,10-tetrahydroxybenz(b)indeno(1,2-d)pyran-9(6H)-one; Benz(b)indeno(1,2-d)pyran-9(6H)-one, 6a,7-dihydro-3,4,6a,10-tetrahydroxy-; 3,4,6a,10-tetrahydroxy-6a,7-dihydroindeno[2,1-c]chromen-9(6H)-one; MFCD00036187; 4,6a,9,10-tetrahydroxy-6,7-dihydroindeno[2,1-c]chromen-3-one; 3,4,6a,10-Tetrahydroxy-6a,7-dihydrobenz(b)indeno(1,2-d)pyran-9(6H)-one; Benz[b]indeno[1, 6a,7-dihydro-3,4,6a,10-tetrahydroxy-; 3,4,6a,10-tetrahydroxy-6a,7-dihydrobenzo[b]indeno[1,2-d]pyran-9(6H)-one

CAS No.: 475-25-2

Compound CID: 135403802

Formula: C₁₆H₁₂O₆

Formula Weight: 300.26

Specification

Stability: 3 years in powder form.

Storage: Storage at -20°C.

Applications: Hematein is used in biochemical research as a natural compound to investigate the inhibition of protein kinases and its potential role in regulating redox-sensitive signaling pathways.